Ga offline met de app Player FM !
Podcasts die het beluisteren waard zijn
GESPONSORDE
![Lipstick on the Rim podcast artwork](https://cdn.player.fm/images/36353102/series/xCZoNvzVfGikvCeg/32.jpg 32w, https://cdn.player.fm/images/36353102/series/xCZoNvzVfGikvCeg/64.jpg 64w, https://cdn.player.fm/images/36353102/series/xCZoNvzVfGikvCeg/128.jpg 128w, https://cdn.player.fm/images/36353102/series/xCZoNvzVfGikvCeg/256.jpg 256w, https://cdn.player.fm/images/36353102/series/xCZoNvzVfGikvCeg/512.jpg 512w)
![Lipstick on the Rim podcast artwork](/static/images/64pixel.png)
1 Amy Schumer & Brianne Howey on the Importance of Female Friendships, Navigating Hollywood's Double Standards, Sharing Their Birth Stories, and MORE 50:05
02_07 HER-2 positive breast cancer: Considerations in advanced disease
Manage episode 352932938 series 3335024
1. Anti-HER2 agent classes
2. Cleopatra Trial
3. Later line options
4. Leptomeningeal carcinomatosis
Citations
As always, citations, and sources include education from our respective training programs, the Devita textbook, and Uptodate.com. We highly encourage review of guidelines published by ASCO, ESMO and other organizations local to your practice.
DeVita, Vincent T., Jr., Theodore S. Lawrence, and Steven A. Rosenberg. Devita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology. 10th edition. Philadelphia: Wolters Kluwer, 2015.
Uptodate.com Waltham, MA: Wolters Kluwer.
Some highlighted references recommended to read related to this specific episode:
1. Dawood S et al. NEJM. 2001;344(11):783-792. doi:10.1056/NEJM200103153441101
3. Baselga J et al. NEJM. 2012;366(2):109-119. doi:10.1056/NEJMOA1113216/
4. Swain SM et al. NEJM. 2015;372(8):724-734. doi:10.1056/NEJMOA1413513/
5. Verma S et al. T. NEJM. 2012;367(19):1783-1791. doi:10.1056/NEJMOA1209124/
6. Cortés J et al. NEJM. 2022;386(12):1143-1154. doi:10.1056/NEJMOA2115022/
7. Krop IE et al. Lancet Oncol. 2017;18(6):743-754. doi:10.1016/S1470-2045(17)30313-3
8. Murthy RK et al. NEJM. 2020;382(7):597-609. doi:10.1056/NEJMOA1914609/
Disclosures
Talking about Tumors with Ryan and Ryann is not medical advice. We have received no funding in relation to the information discussed within this episode and have no financial conflicts of interest to disclose. All opinions are those of whoever stated them. We have compiled this podcast to serve as an introduction to the field of medical oncology for post-graduate trainees interested in the topic.
Tags
Hematology/Oncology, evidence based medicine, education, chemotherapy, immunotherapy, medical oncology
49 afleveringen
02_07 HER-2 positive breast cancer: Considerations in advanced disease
Talking About Tumors with Ryann and Ryan - A medical oncology podcast
Manage episode 352932938 series 3335024
1. Anti-HER2 agent classes
2. Cleopatra Trial
3. Later line options
4. Leptomeningeal carcinomatosis
Citations
As always, citations, and sources include education from our respective training programs, the Devita textbook, and Uptodate.com. We highly encourage review of guidelines published by ASCO, ESMO and other organizations local to your practice.
DeVita, Vincent T., Jr., Theodore S. Lawrence, and Steven A. Rosenberg. Devita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology. 10th edition. Philadelphia: Wolters Kluwer, 2015.
Uptodate.com Waltham, MA: Wolters Kluwer.
Some highlighted references recommended to read related to this specific episode:
1. Dawood S et al. NEJM. 2001;344(11):783-792. doi:10.1056/NEJM200103153441101
3. Baselga J et al. NEJM. 2012;366(2):109-119. doi:10.1056/NEJMOA1113216/
4. Swain SM et al. NEJM. 2015;372(8):724-734. doi:10.1056/NEJMOA1413513/
5. Verma S et al. T. NEJM. 2012;367(19):1783-1791. doi:10.1056/NEJMOA1209124/
6. Cortés J et al. NEJM. 2022;386(12):1143-1154. doi:10.1056/NEJMOA2115022/
7. Krop IE et al. Lancet Oncol. 2017;18(6):743-754. doi:10.1016/S1470-2045(17)30313-3
8. Murthy RK et al. NEJM. 2020;382(7):597-609. doi:10.1056/NEJMOA1914609/
Disclosures
Talking about Tumors with Ryan and Ryann is not medical advice. We have received no funding in relation to the information discussed within this episode and have no financial conflicts of interest to disclose. All opinions are those of whoever stated them. We have compiled this podcast to serve as an introduction to the field of medical oncology for post-graduate trainees interested in the topic.
Tags
Hematology/Oncology, evidence based medicine, education, chemotherapy, immunotherapy, medical oncology
49 afleveringen
Όλα τα επεισόδια
×Welkom op Player FM!
Player FM scant het web op podcasts van hoge kwaliteit waarvan u nu kunt genieten. Het is de beste podcast-app en werkt op Android, iPhone en internet. Aanmelden om abonnementen op verschillende apparaten te synchroniseren.